Epigenetics of Regeneration

Repairing damaged neurons relies on booting a histone deacetylase out of the nucleus so regeneration genes can be turned on.

Written byAbby Olena, PhD
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

CELL IN DISTRESS: In cultured neurons, damage to the axon results in a wave of calcium ions surging toward the cell body (1). Subsequently, the enzyme PKCμ is phosphorylated (2), resulting in the release of histone deacetylase 5 (HDAC5) from the nucleus (3). Following HDAC5’s departure, acetylation of histone H3 increases (4), upregulating the expression of genes involved in regeneration. HDAC5 then ends up congregating at the site of injury (5). © SCOTT LEIGHTON

The paper
Y. Cho et al., “Injury-induced HDAC5 nuclear export is essential for axon regeneration,” Cell, 155:894–908, 2013.

To regenerate after injury, a nerve cell must turn on gene programs that have been silenced since development. Epigenetic modifications, important players in the activation and silencing of genes, may underlie the ability for a cell to rebuild. “At some level, some epigenetic change must occur globally to allow the neuron to reprogram itself,” says Valeria Cavalli of the Washington University School of Medicine in St. Louis, Missouri.

In 2012, Cavalli’s group showed that when axons are injured in peripheral sensory neurons, a wave of calcium ions courses from the site of the injury down the axon to the cell body. Subsequently, histone deacetylase 5 (HDAC5)—an epigenetic ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies